OpGen Inc
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, includ… Read more
OpGen Inc (OPGN) - Total Assets
Latest total assets as of September 2025: $12.64 Million USD
Based on the latest financial reports, OpGen Inc (OPGN) holds total assets worth $12.64 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
OpGen Inc - Total Assets Trend (2012–2025)
This chart illustrates how OpGen Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
OpGen Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
OpGen Inc's total assets of $12.64 Million consist of 26.9% current assets and 73.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.3% |
| Accounts Receivable | $29.26K | 0.3% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how OpGen Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: OpGen Inc's current assets represent 26.9% of total assets in 2025, a decrease from 89.2% in 2012.
- Cash Position: Cash and equivalents constituted 13.3% of total assets in 2025, down from 67.2% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 0.3% of total assets.
OpGen Inc Competitors by Total Assets
Key competitors of OpGen Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
OpGen Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - OpGen Inc generates 0.53x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, OpGen Inc generates $ 121.60 in net profit.
OpGen Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.06 | 5.46 | 1.74 |
| Quick Ratio | 7.06 | 5.46 | 1.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.74 Million | $ 2.63 Million | $ 6.35 Million |
OpGen Inc - Advanced Valuation Insights
This section examines the relationship between OpGen Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 31.97 |
| Latest Market Cap to Assets Ratio | 1.28 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $9.86 Million |
| Market Capitalization | $12.63 Million USD |
Valuation Analysis
Above Book Valuation: The market values OpGen Inc's assets above their book value (1.28 x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: OpGen Inc's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for OpGen Inc (2012–2025)
The table below shows the annual total assets of OpGen Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $9.86 Million | 0.00% |
| 2024-12-31 | $9.86 Million | +423.98% |
| 2023-12-31 | $1.88 Million | -92.71% |
| 2022-12-31 | $25.83 Million | -63.96% |
| 2021-12-31 | $71.67 Million | +44.05% |
| 2020-12-31 | $49.75 Million | +377.37% |
| 2019-12-31 | $10.42 Million | +16.44% |
| 2018-12-31 | $8.95 Million | +35.20% |
| 2017-12-31 | $6.62 Million | -26.31% |
| 2016-12-31 | $8.98 Million | -34.72% |
| 2015-12-31 | $13.76 Million | +418.38% |
| 2014-12-31 | $2.65 Million | -15.95% |
| 2013-12-31 | $3.16 Million | -70.20% |
| 2012-12-31 | $10.60 Million | -- |